Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/180535
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBenseny Cases, Núria-
dc.contributor.authorÁlvarez Marimon, Elena-
dc.contributor.authorAso Pérez, Ester-
dc.contributor.authorCarmona Murillo, Margarita-
dc.contributor.authorKlementieva, Oxana-
dc.contributor.authorAppelhans, Dietmar-
dc.contributor.authorFerrer, Isidre-
dc.contributor.authorCladera, Josep-
dc.date.accessioned2021-10-11T11:12:54Z-
dc.date.available2021-10-11T11:12:54Z-
dc.date.issued2021-09-15-
dc.identifier.issn2045-2322-
dc.identifier.urihttp://hdl.handle.net/2445/180535-
dc.description.abstractAmyloid plaques composed of Aβ amyloid peptides and neurofibrillary tangles are a pathological hallmark of Alzheimer Disease. In situ identification of early-stage amyloid aggregates in Alzheimer's disease is relevant for their importance as potential targets for effective drugs. Synchrotron-based infrared imaging is here used to identify early-stage oligomeric/granular aggregated amyloid species in situ in the brain of APP/PS1 transgenic mice for the first time. Also, APP/PS1 mice show fibrillary aggregates at 6 and 12 months. A significant decreased burden of early-stage aggregates and fibrillary aggregates is obtained following treatment with poly(propylene imine) dendrimers with histidine-maltose shell (a neurodegenerative protector) in 6-month-old APP/PS1 mice, thus demonstrating their putative therapeutic properties of in AD models. Identification, localization, and characterization using infrared imaging of these non-fibrillary species in the cerebral cortex at early stages of AD progression in transgenic mice point to their relevance as putative pharmacological targets. No less important, early detection of these structures may be useful in the search for markers for non-invasive diagnostic techniques.-
dc.format.extent9 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherSpringer Science and Business Media LLC-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1038/s41598-021-96379-4-
dc.relation.ispartofScientific Reports, 2021, vol. 11, num. 1-
dc.relation.urihttps://doi.org/10.1038/s41598-021-96379-4-
dc.rightscc by (c) Benseny Cases, Núria et al, 2021-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.subject.classificationMalaltia d'Alzheimer-
dc.subject.classificationRadiació sincrotrònica-
dc.subject.otherAlzheimer's disease-
dc.subject.otherSynchrotron radiation-
dc.titleIn situ identification and G4-PPI-His-Mal-dendrimer-induced reduction of early-stage amyloid aggregates in Alzheimer’s disease transgenic mice using synchrotron-based infrared imaging-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec720142-
dc.date.updated2021-10-07T07:33:26Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid34526539-
Appears in Collections:Articles publicats en revistes (Patologia i Terapèutica Experimental)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
s41598-021-96379-4.pdf1.54 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons